Physician profile
Steven Hermiz
NPI 1770847709
$3,120.61
in general payments reported to CMS, 2019-2025
19 companies · $710 in 2025
The $710 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $335 · 2021: $1,003 · 2022: $240 · 2023: $301 · 2024: $25.02 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001 · Consulting Fee: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.00 |
| Consulting Fee | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $620.65 | 2021 | |
| Mentor Worldwide LLC | $452.98 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Integra Lifesciences Corporation | $313.98 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $277.64 | 2019-2025 | Restrata Wound Matrix |
| Tela Bio, INC. | $246.43 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sientra, INC. | $188.41 | 2021-2022 | |
| Kls-Martin L.P. | $179.67 | 2021-2025 | |
| Musculoskeletal Transplant Foundation INC. | $140.61 | 2020 | |
| Kci USA, INC. | $126.95 | 2019-2022 | |
| Allergan, INC. | $122.69 | 2021-2022 | |
| Axogen | $116.51 | 2021 | |
| Medtronic, INC. | $83.73 | 2023 | V-Loc 180, Ta |
| Acumed LLC | $80.08 | 2023 | Inframe Implant, Innate Implant |
| Smith+Nephew, INC. | $47.13 | 2023 | Stravix |
| Heron Therapeutics, INC. | $28.76 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $28.40 | 2025 | Surgiphor |
| Baxter Healthcare | $26.00 | 2021 | |
| Abbvie INC. | $25.02 | 2024 | |
| Endo Pharmaceuticals INC. | $14.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Hermiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.